Measurements of β-arrestin recruitment to activated seven transmembrane receptors using enzyme complementation.
The recruitment of arrestins to activated 7TMRs results in the activation of alternative signaling pathways, quenching of G-protein activation, and coupling to clathrin-mediated endocytosis. The nearly ubiquitous involvement of arrestin in 7TMR signaling has spurred the development of several methods for monitoring this interaction in mammalian cells. Nonetheless, few maintain the reproducibility and precision necessary for drug discovery applications. Enzyme fragment complementation technology (EFC) is an emerging protein-protein interaction technology based on the forced complementation of a split enzyme that has proven to be highly effective in monitoring the formation of GPCR-arrestin complexes. In these systems, the target proteins are fused to two fragments of an enzyme that show little or no spontaneous complementation. Interaction of the two proteins forces the complementation of the enzyme, resulting in an enzymatic measure of the protein interaction. This chapter discusses the utility and methods involved in using the PathHunter β-galactosidase complementation system to monitor arrestin recruitment and the advantages of exploiting this pathway in the characterization of 7TMR function.
DiscoveRx Corporation, Fremont, CA, USA.
Daniel L
DL
Bassoni
William J
WJ
Raab
Philip L
PL
Achacoso
Chin Yee
CY
Loh
Tom S
TS
Wehrman
D000818:Animals; D019390:Arrestins / Q000378:metabolism*; D002460:Cell Line; D055808:Drug Discovery / Q000379:methods*; D006801:Humans; D011485:Protein Binding; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism*; D000071557:beta-Arrestins; D001616:beta-Galactosidase / Q000378:metabolism
D019390:Arrestins; D043562:Receptors, G-Protein-Coupled; D000071557:beta-Arrestins; D001616:beta-Galactosidase